These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11844544)

  • 1. Levodopa and recovery after stroke.
    Vinzio S; Goichot B
    Lancet; 2002 Feb; 359(9304):443-4. PubMed ID: 11844544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Madopar in the complex therapy of ischemic insult].
    Odinak MM; Vozniuk IA; Kovalenko PA; Lobzin SV; Ianishevskiĭ SN
    Voen Med Zh; 2005 Jan; 326(1):35-9. PubMed ID: 15754768
    [No Abstract]   [Full Text] [Related]  

  • 3. Role, indications and controversies of levodopa administration in chronic stroke patients.
    Acler M; Manganotti P
    Eur J Phys Rehabil Med; 2013 Apr; 49(2):243-9. PubMed ID: 23558705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic effects on encoding of a motor memory in chronic stroke.
    Floel A; Hummel F; Breitenstein C; Knecht S; Cohen LG
    Neurology; 2005 Aug; 65(3):472-4. PubMed ID: 16087920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial.
    Lokk J; Salman Roghani R; Delbari A
    Acta Neurol Scand; 2011 Apr; 123(4):266-73. PubMed ID: 20569228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
    Restemeyer C; Weiller C; Liepert J
    Restor Neurol Neurosci; 2007; 25(2):143-50. PubMed ID: 17726273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor Outcome of Stroke Patients with Low Dose Levodopa Therapy.
    Das UK; Uddin MJ; Bhattacharjee M; Sarker UK; Talukder RK; Saha G; Rahman MA; Kamal MZ; Banu NR; Shill SK
    Mymensingh Med J; 2019 Oct; 28(4):762-766. PubMed ID: 31599238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa therapy in a Lesch-Nyhan disease patient: pathological, biochemical, neuroimaging, and therapeutic remarks.
    Serrano M; Pérez-Dueñas B; Ormazábal A; Artuch R; Campistol J; Torres RJ; García-Cazorla A
    Mov Disord; 2008 Jul; 23(9):1297-300. PubMed ID: 18528895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From parallel to perpendicular: getting "straightened out" with levodopa therapy.
    Glynn SM; Pittock SJ; Vernino SA
    Mayo Clin Proc; 2004 Jun; 79(6):828-9. PubMed ID: 15182102
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatments of levodopa-induced dyskinesias.
    Vale S
    Lancet; 1999 Aug; 354(9177):511. PubMed ID: 10465195
    [No Abstract]   [Full Text] [Related]  

  • 12. Cervical dystonia responsive to levodopa.
    Singh S; Goyal V; Prasad K; Behari M
    Neurol India; 2004 Jun; 52(2):276-8. PubMed ID: 15269503
    [No Abstract]   [Full Text] [Related]  

  • 13. Akinetic mutism from frontal lobe damage responding to levodopa.
    Combarros O; Infante J; Berciano J
    J Neurol; 2000 Jul; 247(7):568-9. PubMed ID: 10993505
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series.
    Mukand JA; Guilmette TJ; Allen DG; Brown LK; Brown SL; Tober KL; Vandyck WR
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1279-82. PubMed ID: 11552204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke.
    Kuric E; Wieloch T; Ruscher K
    Exp Neurol; 2013 Sep; 247():202-8. PubMed ID: 23664961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopa-responsive dystonic camptocormia.
    Van Gerpen JA
    Neurology; 2006 Jun; 66(11):1779. PubMed ID: 16769967
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors influencing dopaminergic therapy of Parkinson's disease.
    Horowski R
    Funct Neurol; 1988; 3(4):459-70. PubMed ID: 2907501
    [No Abstract]   [Full Text] [Related]  

  • 19. Levodopa does not improve function in individuals with dystonic cerebral palsy.
    Pozin I; Bdolah-Abram T; Ben-Pazi H
    J Child Neurol; 2014 Apr; 29(4):534-7. PubMed ID: 23349519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levodopa in hemifacial spasm. A therapeutic alternative].
    Millán-Guerrero RO; Tene-Pérez E; Trujillo-Hernández B
    Gac Med Mex; 2000; 136(6):565-71. PubMed ID: 11131858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.